CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17
Abstract Background Metastasis causes the vast majority of colorectal carcinoma (CRC)-related deaths. However, little is known about the specific traits and underlying mechanisms of metastasis-initiating cells in primary CRC. And whether or not circular RNAs (circRNAs) take part in this particular e...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-03-01
|
Series: | Molecular Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12943-020-01184-8 |
id |
doaj-380d73f1e2204556af19e4714851a964 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kai Han Feng-Wei Wang Chen-Hui Cao Han Ling Jie-Wei Chen Ri-Xin Chen Zi-Hao Feng Jie Luo Xiao-Han Jin Jin-Ling Duan Shu-Man Li Ning-Fang Ma Jing-Ping Yun Xin-Yuan Guan Zhi-Zhong Pan Ping Lan Rui-Hua Xu Dan Xie |
spellingShingle |
Kai Han Feng-Wei Wang Chen-Hui Cao Han Ling Jie-Wei Chen Ri-Xin Chen Zi-Hao Feng Jie Luo Xiao-Han Jin Jin-Ling Duan Shu-Man Li Ning-Fang Ma Jing-Ping Yun Xin-Yuan Guan Zhi-Zhong Pan Ping Lan Rui-Hua Xu Dan Xie CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 Molecular Cancer Colorectal carcinoma circLONP2 Metastasis microRNA-17 |
author_facet |
Kai Han Feng-Wei Wang Chen-Hui Cao Han Ling Jie-Wei Chen Ri-Xin Chen Zi-Hao Feng Jie Luo Xiao-Han Jin Jin-Ling Duan Shu-Man Li Ning-Fang Ma Jing-Ping Yun Xin-Yuan Guan Zhi-Zhong Pan Ping Lan Rui-Hua Xu Dan Xie |
author_sort |
Kai Han |
title |
CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 |
title_short |
CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 |
title_full |
CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 |
title_fullStr |
CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 |
title_full_unstemmed |
CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17 |
title_sort |
circlonp2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microrna-17 |
publisher |
BMC |
series |
Molecular Cancer |
issn |
1476-4598 |
publishDate |
2020-03-01 |
description |
Abstract Background Metastasis causes the vast majority of colorectal carcinoma (CRC)-related deaths. However, little is known about the specific traits and underlying mechanisms of metastasis-initiating cells in primary CRC. And whether or not circular RNAs (circRNAs) take part in this particular event remain not adequately stated yet. Methods A screening method based on Transwell assay was first applied to build CRC subgroups with different metastatic potential. High throughput RNA sequencing was used to find out novel metastatic drivers in CRC metastasis-initiating step. A series of in vitro and in vivo assays were further applied to elucidate the functions and underlying molecular mechanisms of circRNAs in CRC metastasis. Results A circRNA consisting of exon 8–11 of LONP2, termed as circLONP2, was upregulated in metastasis-initiating CRC subgroups. Aberrant higher expression of circLONP2 was observed in primary CRC tissues with established metastasis, and along the invasive margin in metastatic site. High expression of circLONP2 predicted unfavorable overall survival. Functional studies revealed that circLONP2 could enhance the invasiveness of CRC cells in vitro, and targeting circLONP2 through anti-sense oligonucleotide (ASO) dramatically reduced the penetrance of metastasis to foreign organs in vivo. Mechanically, circLONP2 directly interacted with and promoted the processing of primary microRNA-17 (pri-miR-17), through recruiting DiGeorge syndrome critical region gene 8 (DGCR8) and Drosha complex in DDX1-dependent manner. Meanwhile, upregulated mature miR-17-5p could be assembled into exosomes and internalized by neighboring cells to enhance their aggressiveness. Conclusions Our data indicate that circLONP2 acts as key metastasis-initiating molecule during CRC progression through modulating the intracellular maturation and intercellular transfer of miR-17, resulting in dissemination of metastasis-initiating ability in primary site and acceleration of metastasis formation in foreign organs. circLONP2 could serve as an effective prognostic predictor and/or novel anti-metastasis therapeutic target in CRC treatment. |
topic |
Colorectal carcinoma circLONP2 Metastasis microRNA-17 |
url |
http://link.springer.com/article/10.1186/s12943-020-01184-8 |
work_keys_str_mv |
AT kaihan circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT fengweiwang circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT chenhuicao circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT hanling circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT jieweichen circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT rixinchen circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT zihaofeng circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT jieluo circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT xiaohanjin circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT jinlingduan circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT shumanli circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT ningfangma circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT jingpingyun circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT xinyuanguan circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT zhizhongpan circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT pinglan circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT ruihuaxu circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 AT danxie circlonp2enhancescolorectalcarcinomainvasionandmetastasisthroughmodulatingthematurationandexosomaldisseminationofmicrorna17 |
_version_ |
1724790942332878848 |
spelling |
doaj-380d73f1e2204556af19e4714851a9642020-11-25T02:38:26ZengBMCMolecular Cancer1476-45982020-03-0119111810.1186/s12943-020-01184-8CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17Kai Han0Feng-Wei Wang1Chen-Hui Cao2Han Ling3Jie-Wei Chen4Ri-Xin Chen5Zi-Hao Feng6Jie Luo7Xiao-Han Jin8Jin-Ling Duan9Shu-Man Li10Ning-Fang Ma11Jing-Ping Yun12Xin-Yuan Guan13Zhi-Zhong Pan14Ping Lan15Rui-Hua Xu16Dan Xie17Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineDepartment of Surgery, First Affiliated Hospital, Sun Yat-sen UniversitySun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineKey Laboratory of Protein Modification and Degradation, School of Basic Medical Sciences, Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversitySun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineDepartment of Colorectal Surgery, the Six Affiliated Hospital, Sun Yat-sen UniversitySun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineSun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer MedicineAbstract Background Metastasis causes the vast majority of colorectal carcinoma (CRC)-related deaths. However, little is known about the specific traits and underlying mechanisms of metastasis-initiating cells in primary CRC. And whether or not circular RNAs (circRNAs) take part in this particular event remain not adequately stated yet. Methods A screening method based on Transwell assay was first applied to build CRC subgroups with different metastatic potential. High throughput RNA sequencing was used to find out novel metastatic drivers in CRC metastasis-initiating step. A series of in vitro and in vivo assays were further applied to elucidate the functions and underlying molecular mechanisms of circRNAs in CRC metastasis. Results A circRNA consisting of exon 8–11 of LONP2, termed as circLONP2, was upregulated in metastasis-initiating CRC subgroups. Aberrant higher expression of circLONP2 was observed in primary CRC tissues with established metastasis, and along the invasive margin in metastatic site. High expression of circLONP2 predicted unfavorable overall survival. Functional studies revealed that circLONP2 could enhance the invasiveness of CRC cells in vitro, and targeting circLONP2 through anti-sense oligonucleotide (ASO) dramatically reduced the penetrance of metastasis to foreign organs in vivo. Mechanically, circLONP2 directly interacted with and promoted the processing of primary microRNA-17 (pri-miR-17), through recruiting DiGeorge syndrome critical region gene 8 (DGCR8) and Drosha complex in DDX1-dependent manner. Meanwhile, upregulated mature miR-17-5p could be assembled into exosomes and internalized by neighboring cells to enhance their aggressiveness. Conclusions Our data indicate that circLONP2 acts as key metastasis-initiating molecule during CRC progression through modulating the intracellular maturation and intercellular transfer of miR-17, resulting in dissemination of metastasis-initiating ability in primary site and acceleration of metastasis formation in foreign organs. circLONP2 could serve as an effective prognostic predictor and/or novel anti-metastasis therapeutic target in CRC treatment.http://link.springer.com/article/10.1186/s12943-020-01184-8Colorectal carcinomacircLONP2MetastasismicroRNA-17 |